Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2003-01-07
2010-11-23
Jiang, Shaoijia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S023000, C536S055100, C536S055200, C536S123100, C424S426000
Reexamination Certificate
active
07838510
ABSTRACT:
The use in the medical-surgical field of biomaterials based on hyaluronic acid derivatives, optionally in association with natural, synthetic or semisynthetic biopolymers, for suppressing the angiogenic process associated with tumor proliferation (in primary and secondary tumors) is disclosed.
REFERENCES:
patent: 4851521 (1989-07-01), Della Valle et al.
patent: 5520916 (1996-05-01), Callegaro et al.
patent: 6872819 (2005-03-01), Pavesio et al.
patent: 0341745 (1989-11-01), None
patent: 0466300 (1992-01-01), None
patent: 61000017 (1986-01-01), None
patent: WO 94/23725 (1994-10-01), None
patent: WO 97/07833 (1997-03-01), None
patent: WO 99/61080 (1999-12-01), None
patent: WO 00/01733 (2000-01-01), None
patent: WO 00/54762 (2000-09-01), None
patent: WO 00/57896 (2000-10-01), None
patent: WO 02/18448 (2002-03-01), None
patent: WO 02/18450 (2002-03-01), None
patent: WO 02/41877 (2002-05-01), None
Derwent Abstract of Sakurai et al., JP 61000017, Jan. 6, 1986 (Abstract sent).
STN Abstract of Sakurai et al., JP 61000017, Jan. 6, 1986 (Abstract sent).
Berkeley et al. (Surgery, gynecology & obstetrics, (Mar. 1983) vol. 156, No. 3, pp. 319-22) (Abstract sent).
Tonello et al. “In vitro reconstruction of human dermal equivalent enriched with endothelial cells” Biomaterials, vol. 24, No. 7, Mar. 7, 2003, pp. 1205-1211.
Glass et al. “A three-dimensional cell attachment matrix created by cross-linking RGD peptide modified hyaluronic acid” Journal of Cellular Biochemistry, Suppl. 19A, Jan. 5, 1996, p. 178.
Luo et al. “Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery” Journal of Controlled Release, vol. ,69, No. 1, Oct. 3, 2000, pp. 169-184.
Coradini et al. “Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line” International Journal of Cancer, vol. 81, No. 3, May 5, 1999, pp. 411-416.
Charrad, R. et al., “Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia” Nature Medicine, vol. 5, No. 6, Jun. 1999, pp. 669-676.
Coradini, D. et al., “Hyaluronic Acid As Drug Delivery for Sodium Butyrate: Improvement of the Anti-Proliferative Activity on a Breast-Cancer Cell Line” Int. J. Cancer, vol. 81, 1999, pp. 411-416.
Freemantle, C. et al. “The Modulation of Granulomatous Tissue and Tumour Angiogenesis by Diclofenac in Combination With Hyaluronan (Hyal EX-0001)” Int. J. Tiss. Reac.,—vol. 27, No. 4, 1995, pp. 157-166.
Karasawa, Kenichiro et al., “Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity”Clinical & Experimental Metastasis, vol. 15, No. 2, 1997, pp. 83-93.
Salmon -EHR, V. et al., “Metastases Cutanees De Melanome Situees Sur Une Cicatrice De Prise De Greffe”, Ann. Dermatol. Venereol., vol. 123, 1996, pp. 194-195.
Slevin, M. et al., “Angiogenic Oligosaccharides of Hyaluronan Induce Protein Tyrosine Kinase Activity in Endothelial Cells and Activate a Cytoplasmic Signal Transduction Pathway Resulting in Proliferation”, Laboratory Investigation, vol. 78, No. 8, Aug. 1998, pp. 987-1003.
Hayen, Wiebke et al., “Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture”, Journal of Cell Science, vol. 112, 1999, pp. 2241-2251.
Skobe, Mihaela et al., “Halting angiogenesis suppresses carcinoma cell invasion”, Nature Medicine, vol. 3, No. 11, Nov. 1997, pp. 1222-1227.
Fusenig Norbert E.
Pavesio Alessandra
Stark Hans-Jürgen
Willhauck Michael
Birch & Stewart Kolasch & Birch, LLP
Deutsches Krebsforschungszentrum
Fidia Farmaceutici S.P.A.
Henry Michael C
Jiang Shaoijia Anna
LandOfFree
Biomaterials based on hyaluronic acid for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomaterials based on hyaluronic acid for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomaterials based on hyaluronic acid for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4205036